Procalcitonin kinetics useful for sepsis diagnosis in major burn patients: Study

China: A recent study in the journal Burns showed that procalcitonin (PCT) kinetics early after burn could be a prognostic factor for mortality and sepsis among major burn patients. This implies that serum PCT levels in major burn patients could be a diagnostic biomarker for sepsis.
Severe bacterial infection remains the leading cause of death despite the great advances in the field of burn care. Sepsis is the most common severe complication occurring in major burn patients and is a cause for very high mortality. Early diagnosis followed by adequate antimicrobial therapy is critical for improving the diagnosis of sepsis patients.
Against the above background, Jianglin Tan, State Key Laboratory of Trauma, Burn and Combined Injury, Chongqing, PR China, and colleagues aimed to investigate the clinical significance of PCT kinetics early afterburn and the perioperative period in a retrospective study. Also, they assessed the diagnostic performance for sepsis in major burn patients.
The study included major burn patients (≥40% total body surface area who were admitted to Southwest Hospital, Chongqing, China from 2014 to 2019. A total of 321 patients were included. PCT kinetics was analyzed during the 1st-week afterburn, the perioperative period, and at the onset of clinical suspected sepsis.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.